Table 1.

Estimated Prevalence of HCV Infection by Global Burden of Disease Regions.¹

Regions	Anti-HCV prevalence (CI)	Viremic HCV prevalence (CI)
Asia, Central	5.4% (3.5–6.8%)	2.3% (1.5–3.0%)
Asia, East	1.2% (0.4–1.8%)	0.7% (0.3–1.1%)
Asia, South	1.1% (0.7–1.5%)	0.9% (0.5–1.2%)
Asia, Southeast	1.0% (0.8–1.8%)	0.7% (0.5–1.1%)
Australasia	1.4% (1.0–1.5%)	1.0% (0.8–1.1%)
Caribbean	0.8% (0.2–1.3%)	0.6% (0.1–0.9%)
Europe, Central	1.3% (1.1–1.6%)	1.0% (0.9–1.2%)
North Africa/Middle East	3.1% (2.5–3.9%)	2.1% (1.7–2.6%)
Sub-Saharan Africa, Central	4.2% (2.4–9.2%)	2.6% (1.5–5.5%)

HCV, hepatitis C virus; CI, confidence interval.